Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)
CNY 252.97
(0.34%)
CNY 252.97
(0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 11.21 Billion | 12.14 Billion | 8.99 Billion | 8.87 Billion | 4.72 Billion | 4.03 Billion |
| Net Income | 11.58 Billion | 9.61 Billion | 8 Billion | 6.65 Billion | 4.68 Billion | 3.72 Billion |
| Depreciation & Amortization | 1.03 Billion | 885.05 Million | 700.4 Million | 472.12 Million | 394.3 Million | 331.41 Million |
| Deferred income taxes | -642.4 Million | -174.94 Million | 59.88 Million | -53.62 Million | -49.15 Million | -146.66 Million |
| Stock-based compensation | 217.77 Million | 308 Million | - | - | - | - |
| Change in working capital | -1.39 Billion | 1.34 Billion | 387.89 Million | 1.32 Billion | -514.56 Million | 31.24 Million |
| Other non-cash items | 4.36 Billion | 163.7 Million | -93.7 Million | 416.35 Million | 157.23 Million | -53.81 Million |
| Investing Cash Flow | -802.58 Million | -3.21 Billion | -4.81 Billion | -5.19 Billion | -777.96 Million | -692.61 Million |
| Investments in PPE | -2.68 Billion | -1.91 Billion | -1.4 Billion | -1.18 Billion | -776.86 Million | -678.27 Million |
| Acquisitions | -802.33 Million | 71.48 Million | -3.51 Billion | -26.76 Million | -12.43 Million | -70.07 Million |
| Investment purchases | -1.31 Billion | -36.5 Million | -51.68 Million | -20 Million | -5 Million | -112.65 Million |
| Sales/Maturities of investments | 328.8 Thousand | -71.48 Million | 51.68 Million | 26.76 Million | 12.43 Million | - |
| Other Investing Activities | 4 Billion | -1.26 Billion | 110.05 Million | -3.98 Billion | 3.89 Million | -14.34 Million |
| Financing Cash Flow | -10.82 Billion | -5.19 Billion | -4.6 Billion | -1.85 Billion | -1.24 Billion | 2.89 Billion |
| Debt repayment | -18.76 Million | -103.34 Million | -440.73 Million | - | - | -1.86 Billion |
| Dividends payments | -10.66 Billion | -4.23 Billion | -3.03 Billion | -1.82 Billion | -1.21 Billion | -949.22 Million |
| Common Stock Repurchased | -6.07 Million | -999.94 Million | -999.99 Million | - | - | - |
| Common Stock Issuance | -6.07 Million | 152.43 Million | 999.99 Million | - | -9.33 Million | -15.29 Million |
| Other Financing Activities | -4.35 Million | -10.54 Million | -1.12 Billion | -29.58 Million | -25.88 Million | 5.7 Billion |
| Accounts receivables | -680.9 Million | -1.04 Billion | -153.44 Million | -3.27 Million | -312.25 Million | -247.77 Million |
| Accounts payables | -769.19 Million | 3.09 Billion | 615.08 Million | 2.82 Billion | 553.59 Million | 649.72 Million |
| Inventory | -201.43 Million | -523 Million | -133.63 Million | -1.44 Billion | -706.74 Million | -224.04 Million |
| Other working capital | 253.86 Million | -174.94 Million | 59.88 Million | -53.62 Million | -49.15 Million | 255.28 Million |
| Cash at beginning of period | 19.22 Billion | 15.13 Billion | 15.72 Billion | 14.09 Billion | 11.36 Billion | 4.94 Billion |
| Cash at end of period | 18.78 Billion | 18.97 Billion | 15.13 Billion | 15.72 Billion | 14.09 Billion | 11.36 Billion |
| Capital Expenditure | -2.68 Billion | -1.91 Billion | -1.4 Billion | -1.18 Billion | -776.86 Million | -678.27 Million |
| Effect of forex changes on cash | 101.36 Million | 113.81 Million | -171.44 Million | -197.47 Million | 23.65 Million | 184.14 Million |
| Net cash flow / Change in cash | -433.72 Million | 3.84 Billion | -589.78 Million | 1.62 Billion | 2.72 Billion | 6.41 Billion |
| Free Cash Flow | 8.52 Billion | 10.22 Billion | 7.59 Billion | 7.68 Billion | 3.94 Billion | 3.35 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.07 Billion | 4.4 Billion | 3.15 Billion | 11.58 Billion | 1.74 Billion | 3.39 Billion |
| Depreciation & Amortization | - | 335.1 Million | 335.1 Million | 1.03 Billion | 268.49 Million | -470.11 Million |
| Deferred income taxes | - | - | - | -642.4 Million | - | -1.04 Billion |
| Stock-based compensation | - | 67.57 Million | - | 217.77 Million | 217.77 Million | -159.99 Million |
| Change in working capital | - | -1.04 Billion | - | -1.39 Billion | -628.47 Million | 1.74 Billion |
| Other non-cash items | -497.59 Million | 1.56 Billion | -295.2 Million | 4.36 Billion | 1.96 Billion | -174.44 Million |
| Investing Cash Flow | -579.72 Million | -6.16 Billion | -400.88 Million | -802.58 Million | 3.98 Billion | -2.61 Billion |
| Investments in PPE | -506.85 Million | -508.85 Million | -402.11 Million | -2.68 Billion | -705.72 Million | -919.84 Million |
| Acquisitions | -51.88 Million | -5.64 Billion | 2.29 Million | -802.33 Million | -815.61 Million | 38.95 Million |
| Investment purchases | -581.5 Million | -148.13 Million | -1.06 Million | -1.31 Billion | 54.53 Thousand | -119.49 Million |
| Sales/Maturities of investments | 411.46 Million | 183 Million | - | 328.8 Thousand | - | -38.95 Million |
| Other Investing Activities | 149.05 Million | -39.71 Million | 1.22 Million | 4 Billion | 5.51 Billion | -1.57 Billion |
| Financing Cash Flow | -5.06 Billion | -1.81 Billion | -40.27 Million | -10.82 Billion | -5.22 Billion | -39.39 Million |
| Debt repayment | -2 Million | -1.85 Million | -2.85 Million | -18.76 Million | -18.76 Million | - |
| Dividends payments | -4.92 Billion | -1.81 Billion | -161.77 Thousand | -10.66 Billion | -10.66 Billion | - |
| Common Stock Repurchased | 5.4 Million | -5.4 Million | - | -6.07 Million | -6.07 Million | 6.07 Million |
| Common Stock Issuance | -37.95 Million | 37.95 Million | - | -6.07 Million | -6.07 Million | -291.99 Thousand |
| Other Financing Activities | -148.97 Million | -1.78 Billion | -37.41 Million | -4.35 Million | 5.58 Billion | -45.17 Million |
| Accounts receivables | - | -916.57 Million | - | -680.9 Million | -680.9 Million | 1.25 Billion |
| Accounts payables | - | - | - | -769.19 Million | - | 194 Million |
| Inventory | - | -238.89 Million | - | -201.43 Million | -201.43 Million | 492.34 Million |
| Other working capital | - | 106.57 Million | - | 253.86 Million | 253.86 Million | -194 Million |
| Cash at beginning of period | 18.76 Billion | 21.19 Billion | 18.78 Billion | 19.22 Billion | 19.66 Billion | 15.98 Billion |
| Cash at end of period | 15.58 Billion | 20.59 Billion | 21.19 Billion | 18.78 Billion | 18.78 Billion | 16.53 Billion |
| Capital Expenditure | -506.85 Million | -508.85 Million | -402.11 Million | -2.68 Billion | -705.72 Million | -919.84 Million |
| Effect of forex changes on cash | -111.7 Million | 28.58 Million | -6.5 Million | 101.36 Million | -74.79 Million | -86.6 Million |
| Net cash flow / Change in cash | -3.18 Billion | -595.63 Million | 2.4 Billion | -433.72 Million | -880.08 Million | 549.55 Million |
| Free Cash Flow | 2.07 Billion | 5.12 Billion | 2.46 Billion | 8.52 Billion | 2.74 Billion | 2.36 Billion |
KREN
1410
OSE
601003
GRVO
BGRIM